QVAR Drug Patent Profile
✉ Email this page to a colleague
When do Qvar patents expire, and when can generic versions of Qvar launch?
Qvar is a drug marketed by Teva Branded Pharm and Norton Waterford and is included in two NDAs. There are nineteen patents protecting this drug.
The generic ingredient in QVAR is beclomethasone dipropionate. There are twenty drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the beclomethasone dipropionate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Qvar
A generic version of QVAR was approved as beclomethasone dipropionate by AMNEAL IRELAND LTD on December 16th, 2025.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for QVAR?
- What are the global sales for QVAR?
- What is Average Wholesale Price for QVAR?
Summary for QVAR
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Drug Prices: | Drug price information for QVAR |
| What excipients (inactive ingredients) are in QVAR? | QVAR excipients list |
| DailyMed Link: | QVAR at DailyMed |
US Patents and Regulatory Information for QVAR
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Norton Waterford | QVAR REDIHALER | beclomethasone dipropionate | AEROSOL, METERED;INHALATION | 207921-002 | Aug 3, 2017 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | Y | Y | ⤷ Start Trial | ||
| Norton Waterford | QVAR REDIHALER | beclomethasone dipropionate | AEROSOL, METERED;INHALATION | 207921-002 | Aug 3, 2017 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | Y | Y | ⤷ Start Trial | ||
| Norton Waterford | QVAR REDIHALER | beclomethasone dipropionate | AEROSOL, METERED;INHALATION | 207921-002 | Aug 3, 2017 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | Y | Y | ⤷ Start Trial | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
